CVSI
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
6.18M
70 days until earnings call
ELAN
Price
$18.68
Change
+$0.25 (+1.36%)
Updated
Sep 8, 12:50 PM (EDT)
Capitalization
9.16B
64 days until earnings call
Interact to see
Advertisement

CVSI vs ELAN

Header iconCVSI vs ELAN Comparison
Open Charts CVSI vs ELANBanner chart's image
CV Sciences
Price$0.03
Change-$0.00 (-0.00%)
Volume$39.95K
Capitalization6.18M
Elanco Animal Health
Price$18.68
Change+$0.25 (+1.36%)
Volume$3.17K
Capitalization9.16B
CVSI vs ELAN Comparison Chart in %
Loading...
CVSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVSI vs. ELAN commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVSI is a Hold and ELAN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CVSI: $0.03 vs. ELAN: $18.43)
Brand notoriety: CVSI: Not notable vs. ELAN: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CVSI: 27% vs. ELAN: 91%
Market capitalization -- CVSI: $6.18M vs. ELAN: $9.16B
CVSI [@Pharmaceuticals: Generic] is valued at $6.18M. ELAN’s [@Pharmaceuticals: Generic] market capitalization is $9.16B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVSI’s FA Score shows that 1 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).

  • CVSI’s FA Score: 1 green, 4 red.
  • ELAN’s FA Score: 0 green, 5 red.
According to our system of comparison, CVSI is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVSI’s TA Score shows that 4 TA indicator(s) are bullish while ELAN’s TA Score has 5 bullish TA indicator(s).

  • CVSI’s TA Score: 4 bullish, 6 bearish.
  • ELAN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than CVSI.

Price Growth

CVSI (@Pharmaceuticals: Generic) experienced а -7.16% price change this week, while ELAN (@Pharmaceuticals: Generic) price change was +0.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

CVSI is expected to report earnings on Nov 17, 2025.

ELAN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($9.16B) has a higher market cap than CVSI($6.18M). ELAN has higher P/E ratio than CVSI: ELAN (20.94) vs CVSI (2.50). ELAN YTD gains are higher at: 52.188 vs. CVSI (-0.710). ELAN has higher annual earnings (EBITDA): 1.45B vs. CVSI (-734K). ELAN has more cash in the bank: 539M vs. CVSI (886K). CVSI has less debt than ELAN: CVSI (1.7M) vs ELAN (4.21B). ELAN has higher revenues than CVSI: ELAN (4.48B) vs CVSI (15M).
CVSIELANCVSI / ELAN
Capitalization6.18M9.16B0%
EBITDA-734K1.45B-0%
Gain YTD-0.71052.188-1%
P/E Ratio2.5020.9412%
Revenue15M4.48B0%
Total Cash886K539M0%
Total Debt1.7M4.21B0%
FUNDAMENTALS RATINGS
CVSI vs ELAN: Fundamental Ratings
CVSI
ELAN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9879
PRICE GROWTH RATING
1..100
5638
P/E GROWTH RATING
1..100
2891
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CVSI's Valuation (58) in the null industry is somewhat better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that CVSI’s stock grew somewhat faster than ELAN’s over the last 12 months.

CVSI's Profit vs Risk Rating (100) in the null industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that CVSI’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (79) in the Agricultural Commodities Or Milling industry is in the same range as CVSI (98) in the null industry. This means that ELAN’s stock grew similarly to CVSI’s over the last 12 months.

ELAN's Price Growth Rating (38) in the Agricultural Commodities Or Milling industry is in the same range as CVSI (56) in the null industry. This means that ELAN’s stock grew similarly to CVSI’s over the last 12 months.

CVSI's P/E Growth Rating (28) in the null industry is somewhat better than the same rating for ELAN (91) in the Agricultural Commodities Or Milling industry. This means that CVSI’s stock grew somewhat faster than ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVSIELAN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
60%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
59%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
65%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 4 days ago
62%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 6 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
69%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
CVSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDSB22.950.07
+0.29%
ETC Cabana Target Beta ETF
HYGV40.950.03
+0.07%
FlexShares HY Val-Scrd Bd
JANM32.22-0.01
-0.04%
FT Vest U.S. Eq Max Buffr ETF - Jan
IPAY59.37-0.21
-0.35%
Amplify Digital Payments ETF
JETU23.93-1.16
-4.63%
MAX Airlines 3X Leveraged ETN

CVSI and

Correlation & Price change

A.I.dvisor tells us that CVSI and CANN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVSI and CANN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVSI
1D Price
Change %
CVSI100%
+1.70%
CANN - CVSI
23%
Poorly correlated
-8.42%
ELAN - CVSI
21%
Poorly correlated
+5.50%
BLMH - CVSI
20%
Poorly correlated
-1.59%
CNTMF - CVSI
10%
Poorly correlated
-1.82%
CRRTF - CVSI
7%
Poorly correlated
N/A
More

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with VTRS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+5.50%
VTRS - ELAN
54%
Loosely correlated
+1.65%
ZTS - ELAN
46%
Loosely correlated
+0.08%
EBS - ELAN
39%
Loosely correlated
-0.66%
PAHC - ELAN
37%
Loosely correlated
+0.97%
TLRY - ELAN
35%
Loosely correlated
+3.48%
More